M. Kung

S. Ho, R. Cheung, Y. Song, 2006, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

Single‐nucleotide polymorphism of transient axonal glycoprotein‐1 and its correlation with clinical features and prognosis in chronic inflammatory demyelinating polyneuropathy

K. Chan, S. Ho, T. Tsoi, 2012, Journal of the peripheral nervous system : JPNS.

Long-term inhibition of mutant LRRK2 hyper-kinase activity reduced mouse brain α-synuclein oligomers without adverse effects

J. Mak, S. Ho, S. Yung, 2022, NPJ Parkinson's disease.

Assessment of Cellular Estrogenic Activity Based on Estrogen Receptor-Mediated Reduction of Soluble-Form Catechol-O-Methyltransferase (COMT) Expression in an ELISA-Based System

S. Ho, P. Ho, Song Lu, 2013, PloS one.

Mitochondrial UCP5 is neuroprotective by preserving mitochondrial membrane potential, ATP levels, and reducing oxidative stress in MPP+ and dopamine toxicity.

K. Chan, S. Ho, P. Ho, 2010, Free radical biology & medicine.

Aberrant mitochondrial morphology and function associated with impaired mitophagy and DNM1L-MAPK/ERK signaling are found in aged mutant Parkinsonian LRRK2R1441G mice

S. Ho, P. Ho, S. Pang, 2020, Autophagy.

Neuromyelitis optica‐IgG in idiopathic inflammatory demyelinating disorders amongst Hong Kong Chinese

K. Chan, S. Ho, D. Ramsden, 2009, European journal of neurology.

PMCA4 (ATP2B4) Mutation in Familial Spastic Paraplegia

P. Sham, Miaoxin Li, S. Ho, 2014, PloS one.

Long-term inhibition of mutant LRRK2 hyper-kinase activity reduced mouse brain α-synuclein oligomers without adverse effects

S. Ho, S. Yung, S. Pang, 2022, npj Parkinson's Disease.

Age-dependent accumulation of oligomeric SNCA/α-synuclein from impaired degradation in mutant LRRK2 knockin mouse model of Parkinson disease: role for therapeutic activation of chaperone-mediated autophagy (CMA)

S. Ho, P. Ho, Lingfei Li, 2019, Autophagy.

LRRK2, GBA and their interaction in the regulation of autophagy: implications on therapeutics in Parkinson's disease

S. Ho, S. Pang, D. Ramsden, 2022, Translational neurodegeneration.

Aquaporin-4 water channel expression by thymoma of patients with and without myasthenia gravis

S. Ho, W. Chui, J. Kwan, 2010, Journal of Neuroimmunology.

Cytochrome P4502D6 (debrisoquine 4‐hydroxylase) and Parkinson's disease in Chinese and Caucasians

I. Lauder, S. Ho, D. Ramsden, 1999, European journal of neurology.

Burden of rare variants in ALS genes influences survival in familial and sporadic ALS

P. Sham, Miaoxin Li, K. Cheung, 2017, Neurobiology of Aging.

PMCA4 (ATP2B4) mutation in familial spastic paraplegia causes delay in intracellular calcium extrusion

P. Sham, Miaoxin Li, S. Ho, 2015, Brain and behavior.

Effects of plasticisers and related compounds on the expression of the soluble form of catechol-O-methyltransferase in MCF-7 cells.

S. Ho, D. Ramsden, A. C. Chu, 2008, Current drug metabolism.

Estrogenic phenol and catechol metabolites of PCBs modulate catechol-O-methyltransferase expression via the estrogen receptor: potential contribution to cancer risk.

S. Ho, D. Ramsden, C. Garner, 2008, Current drug metabolism.

In vivo overexpression of synaptogyrin‐3 promotes striatal synaptic dopamine uptake in LRRK2R1441G mutant mouse model of Parkinson's disease

S. Ho, Lingfei Li, S. Pang, 2023, Brain and behavior.

Whole exome sequencing identifies a novel mutation in the transglutaminase 6 gene for spinocerebellar ataxia in a Chinese family

You-Qiang Song, P. Sham, Miaoxin Li, 2013, Clinical genetics.